Clinical importance of intratumoral and normal renal parenchymal inflammatory cell infiltration in renal cell carcinoma

Scandinavian Journal of Urology and Nephrology

Volumn 41, Issue 5, 2007, Pages 387-391

  Soyupek, Sedat ^a,d   Tulunay, Özden ^b   Armaǧan, Abdullah ^a   Hoşcan, Burak ^c   Perk, Hakki ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Alanya Ba kent Hospital   (Turkey)

^d SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Inflammation; Multifocality; Renal cell carcinoma

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CHROMOPHOBE ADENOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; ONCOCYTOMA; PARENCHYMA; PRIORITY JOURNAL; RATING SCALE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INFLAMMATION; KIDNEY NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 35748948690     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590701303645     Document Type: Article

References (24)

1. Mustachi P, Shimkin MS. Cancer of the bladder and infestation with Schistosoma haematobium. J Natl Cancer Inst 1958;20:825-42.
2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
3. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:F23-6.
4. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Int Med 2000;248:171-83.
5. DeMarzo AM, Marchi VL, Epstein JI, Neson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-92.
6. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider LR, et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 1994;86:120-6.
7. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459-67.
8. Donskov F, Bennedsgaard KM, Hokland M, Marcussen N, Fisker R, Madsen HH, et al. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother 2004;53:729-39.
9. Donskov F, Bennedsgaard KM, Von Der Maase H, Marcussen N, Fisker R, Jensen J, et al. Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival. Br J Cancer 2002;87:194-201.
10. Heinemann D, Smith PJ, Symes MO. Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas. Br J Cancer 1987;56:433-7.
11. Tuna B, Yorukoglu K, Gurel D, Mungan U, Kirkali Z. Significance of COX-2 expression in human renal cell carcinoma. Urology 2004;64:1116-20.
12. Hemmerlein B, Markus A, Wehner M, Kugler A, Zschunke F, Radzum HJ. Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas. Cancer Immunol Immunother 2000;49:485-92.
13. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours: tumours of the urinary system and male genital organs. Lyon, France: IARC Press; 2004. p. 9-43.
14. Sobin LH, Wittekind CH. Urological tumours. In: Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. Geneva: UICC; 2002. p. 179-206.
15. Fuhrman SA, Lasky LC, Limas CL. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
16. Lang H, Lindner V, Martin M, Letourneux H, Roy C, Saussine C, et al. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur Urol 2004;45:749-53.
17. Onishi T, Ohishi Y, Goto H, Suzuki M, Miyazawa Y. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients. BJU Int 1999;83:937-43.
18. Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001;61:5132-6.
19. Oya M, Nakamura K, Baba S, Hata J, Tazaki H. Intrarenal satellites of renal cell carcinoma: histopathologic manifestation and clinical implication. Urology 1995;46:161-4.
20. Kletscher BA, Qian J, Bostwick DG, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol 1995;153:904-6.
21. Gohji K, Hara I, Gotoh A, Eto H, Miyake H, Sugiyama T, Okada H, Arakawa S, Kamidono S. Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm. or less. J Urol 1998;159:1144-7.
22. Baltaci S, Orhan D, Soyupek S, Beduk Y, Tulunay O, Gogus O. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urol 2000;164:36-9.
23. Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology 2004;64(3):462-7.
24. Whang M, O'Toole K, Bixon R, Brunetti J, Ikeguchi E, Olsson CA, Sawczuk TS, Benson MC. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. J Urol 1995;154:968-71.